Interleukin-21: updated review of Phase I and II clinical trials in metastatic renal cell carcinoma, metastatic melanoma and relapsed/refractory indolent non-Hodgkin's lymphoma.

Source:http://linkedlifedata.com/resource/pubmed/id/20384523

Download in:

View as

General Info

PMID
20384523